SCHEMBL10150432

SCHEMBL10150432

C=CCC(C)OC(=O)c1c(C)cc(C)cc1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 1/20 0.36
HPGD P15428 4/20 0.35
NPSR1 Q6W5P4 2/20 0.35
MCOLN3 Q8TDD5 1/20 0.35
MAPT P10636 2/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A3 Q01959 1/20 0.34
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 2/20 0.33
LMNA P02545 2/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TCF4 P15884 2/20 0.33
CTNNB1 P35222 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
POLB P06746 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10150593 1.00 CRHR1 (0.36) CRHR1HPGDNPSR1MCOLN3MAPT
SCHEMBL12142624 1.00 CRHR1 (0.36) CRHR1HPGDNPSR1MCOLN3MAPT
SCHEMBL10150434 0.91 CYP3A4 (0.40) CRHR1HPGDALDH1A1HSD17B10TCF4
SCHEMBL10150587 0.85 CRHR1 (0.35) CRHR1HPGDNPSR1MCOLN3MAPT
SCHEMBL10150453 0.85 MAPT (0.33) CRHR1HPGDMAPTSLC6A2SLC6A3
SCHEMBL10150452 0.82 CYP3A4 (0.54) HPGDNPSR1MAPTALDH1A1KDM4E
SCHEMBL10150429 0.82 CRHR1 (0.31) CRHR1
SCHEMBL568833 0.82 HPGD (0.39) HPGDNPSR1MCOLN3MAPTALDH1A1
SCHEMBL10150438 0.81 L3MBTL1 (0.33) HPGDMAPTALDH1A1KDM4ELMNA
SCHEMBL10150596 0.81 L3MBTL1 (0.33) HPGDMAPTALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8450305-B2 Macrocyclic compounds useful as inhibitors of kinases and HSP90 UNIVERSITE DE STRASBOURG (FR) 2013-05-28 US disclosed
US-20120077775-A1 MACROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF KINASES AND HSP90 LE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077775-A1 MACROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF KINASES AND HSP90 HSP90AB1, HSP90AA1, HSP90AB2P CRHR1 1638/4885HPGD 1308/4885NPSR1 3022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.